Petter Bjornstad
Member of Clinical Advisory BoardDr. Petter Bjornstad, M.D., is a Member of Clinical Advisory Board at XORTX Therapeutics Inc since October,2018. He is a NIH and JDRF funded translational researcher with a track record of research potential and success. His lab focuses on metabolic and hemodynamic mechanisms underlying the development of kidney disease, with an emphasis of renal physiology studies, mechanistic clinical trials, mathematical modeling and advanced functional imaging to quantify renal hemodynamic function, energetics and metabolism. Dr. Bjornstad has authored over 70 peer reviewed manuscripts and several high impact journals including Circulation, Lancet Diabetes and Endocrinology, Diabetes Care, Diabetologia, American Journal of Kidney Disease and Journal of Clinical Investigation. Dr. Bjornstad is the Principal investigator of several ongoing studies, including: “Renal HEIR Study: Renal Hemodynamics, Energetics and Insulin Resistance in Youth Onset Type 2 Diabetes Study”, “IMPROVET2D Study: Impact of Metabolic Surgery on Pancreatic, Renal and CardiOVascular HEalth in Youth with Type 2 Diabetes”, “CASPER Study: Copeptin in Adolescent Participants with Type 1 Diabetes and Early Renal Hemodynamic Function”, “Dolphin-T1D Study: Define Renal Oxygenation Levels and Perfusion in Hyperfiltration in Adolescents with Type 1 Diabetes”, and “Diabetic Kidney Alarm (DKA) Study – Tubulopathy in New Onset Diabetic Ketoacidosis”. Dr. Bjornstad is a clinical researcher and an assistant professor of pediatrics and medicine in the department of pediatrics, division of endocrinology and department of medicine, division of nephrology at the University of Colorado School of Medicine.
Positions
- Company NameXORTX Therapeutics Inc.Stock CodeXRTXPositionMember of Clinical Advisory BoardColleagues
- AWAllen Warren DavidoffFounder, Co-CEO, President & Director
- MSMichael Scott BumbyChief Financial Officer
- SHStephen HaworthChief Medical Officer
- SEStacy EvansChief Business Officer
- MGMika GrassoCo-CEO & Director
- RJRichard J. JohnsonMember of Clinical Advisory Board
- ARAnjay RastogiMember of the Clinical Advisory Board
